Palisade Bio (PALI) Enterprise Value (2010 - 2026)

Palisade Bio (PALI) has 17 years of Enterprise Value data on file, last reported at -$132.6 million in Q1 2026.

• On a quarterly basis, Enterprise Value fell 1734.41% year-over-year to -$132.6 million in Q1 2026; TTM through Mar 2026 was -$132.6 million, a 1734.41% decrease from a year earlier, with the FY2025 full-year figure at -$132.4 million, down 1256.13% from the prior year.
• Enterprise Value for Q1 2026 stood at -$132.6 million, roughly flat from -$132.4 million in the prior quarter.
• Over the last five years, Enterprise Value for PALI reached as high as -$5.0 million in Q2 2022 and fell as low as -$132.6 million in Q1 2026.
• Historically, Enterprise Value has averaged -$24.6 million across 5 years, with a median of -$11.4 million in 2024.
• Across the five-year window, Enterprise Value surged 60.64% in 2022 and tumbled 1734.41% in 2026, its largest moves.
• Year by year, Enterprise Value stood at -$12.4 million in 2022, then decreased by 0.4% to -$12.4 million in 2023, then increased by 21.47% to -$9.8 million in 2024, then slumped by 1256.13% to -$132.4 million in 2025, then slipped by 0.17% to -$132.6 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$132.6 million in Q1 2026, -$132.4 million in Q4 2025, and -$5.2 million in Q3 2025.